Abstract
Background: Low-grade inflammation occurs in ∼30% of individuals with major depressive disorder (MDD) and is linked to poorer treatment outcomes, autonomic dysregulation, and elevated cardiometabolic risk. Such inflammation may contribute to variability in response to intermittent theta burst stimulation (iTBS) of the left dorsolateral prefrontal cortex. We tested whether baseline inflammation moderates the association between heart–brain coupling (HBC) during iTBS and clinical improvement, and examined neuroimaging correlates of inflammatory status. Methods: Inflammation was indexed using routine clinical markers: white blood cell count (WBC) and C-reactive protein (CRP). HBC, a physiological marker of frontal-vagal engagement, was derived from electrocardiographic recordings obtained during the first iTBS sessions. Diffusion MRI free-water metrics were used to assess white-matter microstructural alterations associated with inflammation. Results: Higher HBC was associated with symptom improvement only among individuals with lower WBC. Patients with higher WBC counts showed elevated free-water diffusion MRI signal in the fornix and corpus callosum, suggesting possible inflammation-related white matter differences warranting replication. Conclusions: Baseline WBC moderated the association between HBC and clinical response and may contribute to inter-individual variability in iTBS outcomes. Routine inflammatory markers could support stratification approaches for biomarker-guided neuromodulation in MDD. HIGHLIGHTS: Baseline WBC moderates HBC–iTBS response in major depression High HBC was associated with improvement primarily at lower WBC levels (≈<6.44×10□/L) CRP does not significantly moderate HBC–response associations Exploratory DTI analyses linked higher WBC to increased free-water in the fornix & corpus callosum WBC may be a candidate low-cost stratification marker for future biomarker-guided neuromodulation studies.

This publication has 89 references indexed in Scilit: